OvuSense™ is the only fertility monitor that can predict ovulation 24 hours in advance, the potential to diagnose ovulatory issues and monitor treatment.
Operating from UK and US subsidiary hubs, OvuSense is a highly scalable direct to consumer subscription business for fertility and menstrual cycle tracking for screening and treatment monitoring. It has grown into a significant contributor of cash to the business with three secure revenue streams reaching run-rate sales of $1.2m p.a., and over 60,000 online support group members.